Molecular Basis of Synergistic Tau Amyloid Core Inhibition by K311/K353 Acetylation via Microsecond MD Simulations

Jiaxuan Wu1, Xinyu He1, Minghua Fu2

  • 1Wisdom Lake Academy of Pharmacy, Xi'an Jiaotong-Liverpool University, Suzhou 215123, China.

Insights

Acetylation of Tau proteins at K311 and K353 inhibits early aggregation by disrupting dimerization. Dual acetylation shows synergistic effects, reducing beta-sheet formation and offering insight into Alzheimer

Area of Science:

  • Biochemistry
  • Neuroscience
  • Computational Biology

Background:

  • Neurofibrillary tangles, comprising aggregated Tau proteins, are key pathological markers of Alzheimer's disease (AD).
  • The amyloid core of these tangles is mainly formed by Tau's microtubule-binding (MTB) repeats.
  • The precise atomic mechanisms by which Tau acetylation regulates aggregation remain unclear, especially regarding cooperative effects of dual acetylation.

Purpose of the Study:

  • To investigate the atomic-level mechanisms of Tau's MTB repeat dimerization.
  • To determine how site-specific acetylation at K311 and K353 affects Tau dimerization and early amyloid formation.
  • To explore potential cooperative effects of dual acetylation on Tau aggregation.

Main Methods:

  • Microsecond-scale all-atom molecular dynamics simulations were employed.
  • Systematic examination of dimerization dynamics for the four Tau MTB repeat homodimers (R1-R4).
  • Analysis of structural changes, salt bridges, and hydrophobic interactions upon acetylation.

Main Results:

  • R3 and R4 repeats exhibit higher aggregation propensity due to β-sheet-prone sequences containing K311 and K353.
  • Acetylation at K353 moderately destabilizes the R4 dimer, increasing conformational disorder.
  • Acetylation at K311 significantly inhibits R3 dimerization by disrupting salt bridges and π-cation interactions within the PHF6 motif.
  • Dual acetylation of K311 and K353 exhibits a synergistic effect, markedly reducing β-sheet formation beyond additive inhibition.

Conclusions:

  • Acetylation at K311 and K353 acts as a molecular brake on Tau dimerization and early amyloid nucleation.
  • Dual acetylation provides a stronger-than-additive inhibitory effect on β-sheet formation, suggesting cooperative mechanisms.
  • These findings offer mechanistic insights into how lysine acetylation regulates Tau aggregation in Alzheimer's disease.